Escala Medical, a expertise firm specializing within the remedy of pelvic organ prolapse, has secured $4.5 million in funding.
EIC Fund led the spherical, which follows a $2.9 million (€2.5 million) grant awarded to Escala in 2023 by way of the EIC Accelerator program.
WHAT IT DOES
Escala’s product Mendit works to revive pelvic organ operate utilizing a way that removes the necessity for tissue incision or dissection to attach the sacrospinous ligament to the vaginal wall.
The gadget includes a navigation, anchoring and deployment mechanism. The applicator tip is guided to the ligament utilizing the finger, the place it then securely anchors the vaginal wall in its correct anatomical place.
In keeping with the corporate, the process may be finished in an outpatient setting.
Escala will make the most of the funds to increase its business operations within the U.S. and assist its entry into the European market. The corporate will even use the cash to additional worldwide development via a signed distribution settlement with a accomplice primarily based in Singapore.
“This funding marks an necessary milestone as we proceed to scale our operations and convey our breakthrough expertise to extra ladies worldwide,” Edit Goldberg, CEO of Escala, mentioned in a press release.
“We’re proud to have the assist of the EIB and our personal buyers and we stay dedicated to advancing the following technology of our Mendit gadget to enhance outcomes and increase entry to tens of millions of girls worldwide that suffer from organ prolapse.”
MARKET SNAPSHOT
Different corporations within the pelvic well being area embody Origin, which entered into a partnership in March with ladies’s telehealth firm Wisp to permit their members to entry one another’s providers.
Hybrid care supplier Origin gives bodily remedy for the pelvic flooring and the entire physique to enhance sexual well being throughout being pregnant, postpartum and menopause.
Wisp gives same-day appointments for girls looking for remedy for sexual and reproductive well being instruments. Sufferers can join with a licensed medical supplier and, if wanted, receive a prescription for same-day in-person pickup or dwelling supply.
The corporate gives remedies for reproductive well being, vaginal well being, weight care, hormonal well being and extra.
Earlier this month, Sword Well being raised $40 million, bringing its complete funding to $380 million and its valuation to $4 billion. Sword used the funds to assist its international growth, additional develop its AI fashions throughout varied areas of care and speed up its momentum in mergers and acquisitions.
In 2024, Axena Health, which develops a digital therapeutic for women’s pelvic health, partnered with the direct-to-consumer telehealth firm UpScriptHealth to supply consultations and remedy to ladies experiencing urinary incontinence signs.
Axena’s Leva Pelvic Well being System helps ladies with pelvic flooring muscle coaching (PFMT), a first-line remedy that may be accomplished at dwelling.
In 2023, Axena Well being raised a $25 million Series A funding from XA IM Alts.
Axena gives the Leva Pelvic Well being System, a prescription digital therapeutic geared toward treating urinary incontinence and continual fecal incontinence in ladies.
The system, which has acquired FDA 510(k) clearance, features a vaginal movement sensor that connects to an app, guiding customers via pelvic flooring muscle coaching.
In keeping with an Axena spokesperson, the corporate acquired the system from Renovia, which developed and commercialized Leva earlier than it shut down in 2022. final yr. Renovia had beforehand raised $17 million in Series C-1 financing in 2021 and a $32.3 million Series B in 2018.
In 2022, Digital musculoskeletal care firm SWORD Health launched a ladies’s bodily therapy product centered on pelvic well being and ache.
The product, Bloom, features a sensor that measures the strain and stamina of the pelvic flooring and connects to an app, permitting customers to obtain suggestions on their workout routines.
Members are paired with a pelvic well being specialist who guides them via workout routines and makes adjustments to their program primarily based on their wants and outcomes.
That very same yr, Hinge Health launched a ladies’s pelvic health program. Hinge’s program, out there throughout the identical platform as the remainder of its musculoskeletal instruments, gives instructional content material and entry to a care crew comprising bodily therapists, ladies’s well being coaches and urogynecologists.
Hinge went public in Could, elevating $437.3 million in its preliminary public providing. which offered 9.14 million shares. Hinge opened on the NYSE at a inventory value of $39.25 per share, 23% larger than its initially anticipated IPO value of $32.
The corporate’s stock is now trading at $51.80 per share.
Trending Merchandise
